News

New Data from Semaglutide Trials Provides Critical Insights to Guide Next Generation of Therapies Targeting Alzheimer’s Pathobiology

Exploring GLP-1 drugs as preventive therapy may still hold promise within broader strategy targeting Alzheimer’s pathways beyond amyloid, ADDF notes SAN DIEGO, Dec. 4, 2025 /PRNewswire/ — Today, Novo Nordisk presented new topline results from […]

News

Atraverse Medical Secures FDA 510(k) Clearance for HOTWIRE™ RF Generator & Fully Integrated Transseptal Access System

Atraverse Medical also approaches first 2,000 successful clinical procedures using the company’s innovative HOTWIRE™ radiofrequency (RF) guidewire. SAN DIEGO, Dec. 4, 2025 /PRNewswire/ — Atraverse Medical, a medical device company pioneering next-generation left-heart access technology,… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma

CARLSBAD, Calif.–(BUSINESS WIRE)– #ASH–Arima Genomics, a company leveraging whole-genome sequence and structure information, today announced new data to be presented at ASH. Click here to view original post Click Here to Publish/Feature Your Company or […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment

STOCKHOLM, Dec. 4, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai presented the latest findings on time saved with continued treatment with lecanemab (Leqembi®) at the 18th Clinical Trials in Alzheimer’s […]

News

Sanguine Biosciences Expands Clinical Biospecimen Portfolio With New Synovial Fluid and Skin Punch Biopsy Offerings

New sample types strengthen support for autoimmune, dermatology, rheumatology, and inflammation research SAN DIEGO, Dec. 3, 2025 /PRNewswire/ — Sanguine Biosciences, a leading provider of high-quality human biospecimens and real-world clinical data, today announced the […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy

SAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced positive topline results from its pivotal […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Curebound Names Robin Toft as Chief Executive Officer

SAN DIEGO–(BUSINESS WIRE)– #ExecutiveSearch–Curebound today announced that Robin Toft has been appointed chief executive officer, effective January 1. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech […]

News

5 Ways UC San Diego Is Transforming Alzheimer’s Research and Care

UC?San?Diego’s Alzheimer’s program integrates early detection, breakthrough therapies, long?term studies, a one?stop multidisciplinary clinic, and a workforce?training pipeline, advancing research, care, and community outreach to confront the growing dementia crisis. Click here to view original […]


ADVERTISEMENT — Advertise With Biotech Networks
News

ALASKA AIRLINES DONATES 2 MILLION MILES TO RADY CHILDREN’S HEALTH TO ADVANCE PEDIATRIC HEALTHCARE

SAN DIEGO, Dec. 2, 2025 /PRNewswire/ — Alaska Airlines and Rady Children’s Health, the largest pediatric healthcare system in the West, have announced a new collaboration designed to champion pediatric healthcare together. Alaska Airlines’ donation […]

News

CliniComp Named a Top 50 Healthcare Technology Company by The Healthcare Technology Report for Second Consecutive Year

EHR innovator recognized for development of world-class SYaaS model to reduce clinician burnout and increase operational success for health systems SAN DIEGO, Dec. 2, 2025 /PRNewswire/ — CliniComp, the pioneer of a high-performing, reliable electronic […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC

SAN DIEGO–(BUSINESS WIRE)—- $JANX–Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC Click here to view original post Click Here to Publish/Feature Your Company or Product News […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

AltPep Corporation Presents New Preclinical Data at CTAD 2025 Demonstrating SOBIN-AD, its Custom-Designed Peptide for Alzheimer’s Disease, Improves Behavior in Both Symptomatic and Asymptomatic Disease

SEATTLE–(BUSINESS WIRE)– #Alzheimers–AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, will present preclinical data at the Clinical Trials on Alzheimer’s Disease Conference (CTAD), taking place December […]

News

Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer’s Disease

Financing accelerates clinical validation and commercial readiness, as circular RNAs emerge as a new category of brain-derived blood biomarkers with best-in-class performance SAN DIEGO, Dec. 1, 2025 /PRNewswire/ — Circular Genomics, Inc., the world-leading developer […]

No Picture
News

INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer’s Patients

Boca Raton, FL, Dec. 01, 2025 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing inflammation and immunology therapies targeting innate immune dysfunction, announces new neuroimaging data from its Phase 2 […]